Document and Entity Information
Document and Entity Information Document | Jun. 02, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jun. 2, 2022 |
Entity Registrant Name | AMNEAL PHARMACEUTICALS, INC. |
Entity Central Index Key | 0001723128 |
Entity Emerging Growth Company | false |
Entity File Number | 001-38485 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 32-0546926 |
Entity Address, Address Line One | 400 Crossing Blvd |
Entity Address, City or Town | Bridgewater |
Entity Address, State or Province | NJ |
Entity Address, Postal Zip Code | 08807 |
City Area Code | 908 |
Local Phone Number | 947-3120 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Class A Common Stock, par value $0.01 per share |
Trading Symbol | AMRX |
Security Exchange Name | NYSE |